Related Experiment Video

Updated: Oct 30, 2025

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

12.6K

Toll-Like Receptor Signaling Pathways: Novel Therapeutic Targets for Cerebrovascular Disorders

Rezan Ashayeri Ahmadabad1, Zahra Mirzaasgari1,2, Ali Gorji1,3,4,5,6

  • 1Shefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran 1996835911, Iran.

International Journal of Molecular Sciences
|July 2, 2021
PubMed

Insights

Toll-like receptors (TLRs) modulate inflammation in cerebrovascular diseases (CVDs). Targeting TLRs may offer neuroprotection and improve outcomes after brain ischemia by managing neuroinflammation.

Area of Science:

  • Immunology
  • Neuroscience
  • Pathology

Background:

  • Toll-like receptors (TLRs) are pattern recognition proteins crucial for regulating systemic inflammation.
  • Cerebrovascular diseases (CVDs) involve brain tissue damage due to disrupted oxygen and glucose supply.
  • TLRs are implicated in inflammatory responses following hypoxic-ischemic events in CVDs, influencing neuroprotection or damage.

Purpose of the Study:

  • To review the role of TLR signaling pathways in inflammatory responses associated with CVDs.
  • To explore the potential of modulating TLRs for improved functional outcomes after brain ischemia.

Main Methods:

  • Literature review of studies on TLRs and CVDs.
  • Analysis of TLR signaling pathways and downstream inflammatory mediators.
  • Discussion of therapeutic potential of TLR modulation in neuroinflammation.

Main Results:

  • TLRs significantly contribute to the inflammatory cascades in CVDs.
  • TLR signaling activates immune responses through the release of inflammatory mediators.
  • The effects of TLRs in CVDs can be either neuroprotective or detrimental.

Conclusions:

  • Modulating TLR signaling pathways is a key factor in managing neuroinflammation in CVDs.
  • Targeting specific TLRs presents a promising therapeutic strategy to enhance recovery and functional outcomes post-brain ischemia.
Keywords:
braincell injurychemokinesinflammatory mediatorsstroke

More Related Videos

Author Spotlight: Modeling Vascular Contributions to Alzheimer's Disease in Transgenic Mice04:29

Author Spotlight: Modeling Vascular Contributions to Alzheimer's Disease in Transgenic Mice

Published on: May 17, 2024

840
Assessment of Vascular Regeneration in the CNS Using the Mouse Retina07:32

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina

Published on: June 23, 2014

14.6K

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.7K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.3K
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
4.3K
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.8K